Salkind Gene
SEC CIK 1592481 · EDGAR
BoughtSold
Most active insiders at UPXI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Salkind Gene | Dir | $673.5K | — |
| 2 | MARSHALL ALLAN | CEO, Dir | $400.5K | — |
| 3 | Rudick Brian Benjamin | Chief Strategy Off | — | — |
| 4 | Dugan Lawrence | Dir | — | — |
| 5 | Norstrud Andrew James | CFO, Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-20 17:36 | 2026-07-03 | UPXI | UPEXI, INC. | Salkind Gene | Dir | A - Grant | $0.00 | +100.0K | 318.8K | +46% | $0 | |
| 2026-02-13 | 2026-02-11 | ZSQR | Z Squared Inc. | Salkind Gene | Dir | M - OptEx | $10.56 | +5,700 | 13.2K | +76% | +$60.2K | |
| 2026-02-13 | 2026-02-11 | ZSQR | Z Squared Inc. | Salkind Gene | Dir | A - Grant | $0.00 | +3,250 | 13.2K | +33% | $0 | |
| I | 2025-11-21 | 2025-11-20 | UPXI | UPEXI, INC. | Salkind Gene | Dir | P - Purchase | $2.55 | +50.0K | 218.8K | +30% | +$127.5K |
| I | 2025-11-18 | 2025-11-17 | UPXI | UPEXI, INC. | Salkind Gene | Dir | P - Purchase | $2.81 | +100.0K | 168.8K | +145% | +$281.0K |
| 2025-11-18 | 2025-11-17 | UPXI | UPEXI, INC. | Salkind Gene | Dir | P - Purchase | $2.65 | +100.0K | 569.5K | +21% | +$265.0K | |
| M | 2025-07-30 | 2025-07-16 | UPXI | UPEXI, INC. | Salkind Gene | Dir, 10% | A - Grant | $0.00 | +200.0K | 435.4K | +85% | $0 |
| 2025-07-30 | 2025-07-11 | UPXI | UPEXI, INC. | Salkind Gene | Dir, 10% | P - Purchase | $4.94 | +20.2K | 385.4K | +6% | +$100.0K | |
| D | 2025-04-25 | 2025-04-17 | UPXI | UPEXI, INC. | Salkind Gene | Dir, 10% | P - Purchase | $2.28 | +241.2K | 365.1K | +195% | +$550.0K |
| 2024-01-09 | 2024-01-05 | ZSQR | Z Squared Inc. | Salkind Gene | Dir | P - Purchase | $0.69 | +11.6K | 284.1K | +4% | +$8,004 | |
| MI | 2023-08-30 | 2023-08-25+ | ZSQR | Z Squared Inc. | Salkind Gene | Dir | P - Purchase | $0.9223 | +32.6K | 28.6K | New | +$30.1K |
| I | 2022-04-01 | 2022-03-30 | UPXI | UPEXI, INC. | Salkind Gene | Dir, 10% | P - Purchase | $4.00 | +125.0K | 125.0K | New | +$500.0K |
Purchase Sale Sale after option exercise All abbreviations